MORGAN STANLEY - EDITAS MEDICINE INC ownership

EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 315 filers reported holding EDITAS MEDICINE INC in Q4 2020. The put-call ratio across all filers is 0.67 and the average weighting 0.1%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of EDITAS MEDICINE INC
ValueSharesWeighting
Q3 2023$10,410,635
-25.8%
1,334,697
-21.7%
0.00%0.0%
Q2 2023$14,031,803
+120.8%
1,704,958
+94.5%
0.00%0.0%
Q1 2023$6,354,170
-18.9%
876,437
-0.8%
0.00%0.0%
Q4 2022$7,834,958
-29.3%
883,310
-2.5%
0.00%
-50.0%
Q3 2022$11,086,000
-12.4%
905,736
-15.4%
0.00%0.0%
Q2 2022$12,662,000
-40.7%
1,070,453
-4.6%
0.00%
-33.3%
Q1 2022$21,336,000
-16.9%
1,121,770
+16.0%
0.00%0.0%
Q4 2021$25,665,000
-31.6%
966,698
+5.9%
0.00%
-40.0%
Q3 2021$37,510,000
-18.2%
913,048
+12.8%
0.01%
-16.7%
Q2 2021$45,849,000
+13.0%
809,459
-16.2%
0.01%0.0%
Q1 2021$40,586,000
-30.6%
966,297
+15.8%
0.01%
-33.3%
Q4 2020$58,504,000
+93.6%
834,453
-22.5%
0.01%
+50.0%
Q3 2020$30,223,000
+3.1%
1,077,119
+8.7%
0.01%0.0%
Q2 2020$29,311,000
+93.5%
990,890
+29.7%
0.01%
+50.0%
Q1 2020$15,146,000
-54.7%
763,822
-32.4%
0.00%
-50.0%
Q4 2019$33,447,000
+40.7%
1,129,544
+8.1%
0.01%
+33.3%
Q3 2019$23,766,000
+13.1%
1,045,078
+23.0%
0.01%0.0%
Q2 2019$21,022,000
-54.2%
849,732
-54.7%
0.01%
-53.8%
Q1 2019$45,909,000
+6.4%
1,877,685
-1.0%
0.01%0.0%
Q4 2018$43,161,000
-21.7%
1,897,163
+9.5%
0.01%
-7.1%
Q3 2018$55,111,000
-25.7%
1,731,968
-16.3%
0.01%
-30.0%
Q2 2018$74,142,000
+18.8%
2,069,280
+9.9%
0.02%
+17.6%
Q1 2018$62,431,000
+226.6%
1,883,262
+202.8%
0.02%
+240.0%
Q4 2017$19,114,000
+41.4%
622,019
+10.5%
0.01%
+25.0%
Q3 2017$13,516,000
+74.4%
562,936
+21.9%
0.00%
+100.0%
Q2 2017$7,748,000
-43.8%
461,700
-25.3%
0.00%0.0%
Q1 2017$13,790,000
+103.9%
617,818
+48.3%
0.00%
+100.0%
Q4 2016$6,762,000
+98.8%
416,648
+65.1%
0.00%0.0%
Q3 2016$3,402,000
-53.3%
252,351
-15.4%
0.00%
-66.7%
Q2 2016$7,282,000
+47.7%
298,460
+109.1%
0.00%
+50.0%
Q1 2016$4,931,000142,7540.00%
Other shareholders
EDITAS MEDICINE INC shareholders Q4 2020
NameSharesValueWeighting ↓
NIA IMPACT ADVISORS, LLC 54,615$4,897,0002.55%
Capital Impact Advisors, LLC 130,000$9,114,0002.24%
ARK Investment Management 10,125,564$709,903,0001.89%
Nikko Asset Management Americas, Inc. 4,388,143$307,653,0001.75%
Spectrum Planning & Advisory Services Inc. 17,522$1,228,0001.32%
DDD Partners, LLC 79,527$5,576,0001.10%
Brevan Howard Capital Management LP 76,420$5,358,0001.08%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 538,721$37,770,0000.75%
DC Investments Management, LLC 3,627$254,0000.63%
Haafor (Singapore) Pte. Ltd. 4,761$334,0000.62%
View complete list of EDITAS MEDICINE INC shareholders